Harini Bollempalli

Harini Bollempalli practices at HonorHealth in Phoenix, Arizona.

Harini Bollempalli's NPI, 1568994408, was assigned on March 30, 2017. Harini Bollempalli holds Texas license S6362.

Harini Bollempalli's primary practice is HonorHealth, at 2500 W Utopia Rd, Phoenix, AZ 85027 in Maricopa County. The practice phone is (480) 784-5500.

Harini Bollempalli's primary practice is HonorHealth in Phoenix, Arizona. Harini Bollempalli is also affiliated with HonorHealth John C. Lincoln Medical Center. The medical group on file is HonorHealth Medical Group. Dmand AI also links Harini Bollempalli to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Harini Bollempalli practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Harini Bollempalli's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Harini Bollempalli is licensed in Texas.

CMS data shows 663 Medicare services from Harini Bollempalli across 11 procedure codes in 2024, for 208 Medicare patients. Medicare paid $45,375 for them.

CMS counts 208 Medicare patients who saw Harini Bollempalli in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Harini Bollempalli's median patient age at 73, with 52% women.

In 2024, Harini Bollempalli wrote 188 Medicare Part D claims for 88 patients. 85% of them were for generic drugs. CMS names the drug for 106 of them, across 7 drugs with 11 or more claims each, at $12,143 in total drug cost. In 2023, CMS named 67 claims across 4 drugs.

Harini Bollempalli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Harini Bollempalli as offering telehealth.

CMS Open Payments shows 10 general payments to Harini Bollempalli from 5 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 77% of the total. Biosense Webster, Inc. paid the most, $2,500.